Acer Therapeutics Inc (NASDAQ:ACER)
| 1.52 Delayed Data As of 3:59pm ET |  0.00 / 0.00%Today’s Change | 1.16 Today|||52-Week Range 3.77 | -33.33% Year-to-Date |
Latest ACER News | Press Releases
| New Strong Sell Stocks for July 28th Jul 28 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.52 |
| Today’s open | 1.52 |
| Day’s range | 1.51 - 1.52 |
| Volume | 135 |
| Average volume (3 months) | 389,086 |
| Market cap | $24.5M |
Data as of 3:59pm ET, 08/10/2022
Growth & Valuation
| Earnings growth (last year) | +47.64% |
| Earnings growth (this year) | -201.23% |
| Earnings growth (next 5 years) | +10.50% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 25.82 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CEMIChembio Diagnostics ... | -0.01 | -0.91% |
| ONTXOnconova Therapeutic... | +0.01 | +0.78% |
| PBLAPanbela Therapeutics... | 0.00 | 0.00% |
| SPROSpero Therapeutics I... | +0.06 | +8.22% |
Data as of 4:00pm ET, 08/10/2022
Financials
| Next reporting date | August 16, 2022 |
| EPS forecast (this quarter) | -$0.59 |
| Annual revenue (last year) | $1.3M |
| Annual profit (last year) | -$15.4M |
| Net profit margin | -1,220.16% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Newton, Massachusetts |
Forecasts
